123 related articles for article (PubMed ID: 8482551)
1. CA125 measurement in epithelial ovarian cancer: a 10-year anniversary of clinical investigation.
Berkowitz RS
Gynecol Oncol; 1993 Apr; 49(1):1-2. PubMed ID: 8482551
[No Abstract] [Full Text] [Related]
2. Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
Makar AP; Kristensen GB; Børmer OP; Tropé CG
Gynecol Oncol; 1993 Apr; 49(1):3-7. PubMed ID: 8482556
[TBL] [Abstract][Full Text] [Related]
3. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
Liu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of the estimation of growth kinetics of primary ovarian cancer recurrences by CA125 doubling time].
Riedinger JM; Coudert B; Barillot I; Buffenoir G; Mayer F; Fargeot P; Cuisenier J; Guerrin J
Bull Cancer; 1997 Sep; 84(9):855-60. PubMed ID: 9435806
[TBL] [Abstract][Full Text] [Related]
5. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
Yu Q; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
Ryuko K; Iwanari O; Kitao M; Moriwaki S
Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
[TBL] [Abstract][Full Text] [Related]
7. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
Fisken J; Leonard RC; Roulston JE
Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of CA 125 initial half-life measured during first-line chemotherapy in 62 patients with epithelial ovarian cancer stage III or IV].
Riedinger JM; Barillot I; Coudert B; Fargeot P; Berriolo-Riedinger A; Guerrin J
Bull Cancer; 1996 Aug; 83(8):654-63. PubMed ID: 8869046
[TBL] [Abstract][Full Text] [Related]
9. Should we regard CA125 as the indication to treat relapsing ovarian cancer?
Fisken J; Leonard RC; Roulston JE
Ann Oncol; 1993 Mar; 4(3):257. PubMed ID: 8471561
[No Abstract] [Full Text] [Related]
10. The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma.
Hawkins RE; Roberts K; Wiltshaw E; Mundy J; McCready VR
Br J Cancer; 1989 Oct; 60(4):634-7. PubMed ID: 2803938
[TBL] [Abstract][Full Text] [Related]
11. [CA 125, a marker of ovarian epithelial tumors].
Ruibal A
Med Clin (Barc); 1988 Jun; 91(2):54-7. PubMed ID: 3050307
[No Abstract] [Full Text] [Related]
12. [Tumor markers in epithelial carcinoma of the ovary].
Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
[No Abstract] [Full Text] [Related]
13. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies MA54 and MA61 as potential reagents in the prognosis of patients with ovarian cancer.
Kobayashi H; Ohi H; Sugimura M; Shinohara H; Terao T
Gynecol Oncol; 1993 Apr; 49(1):80-5. PubMed ID: 8482565
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
Patsner B; Mann WJ; Chalas E
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
[No Abstract] [Full Text] [Related]
16. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
17. [Significance of CA-125 antigen in the monitoring of therapy and clinical course of ovarian cancer].
Pulay T; Csömör S
Orv Hetil; 1987 Dec; 128(50):2615-9. PubMed ID: 3323994
[No Abstract] [Full Text] [Related]
18. [Epithelial ovarian carcinomas: what to do after recurrences?].
Bobin JY
Rev Prat; 2004 Oct; 54(16):1787-90. PubMed ID: 15630883
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors].
Gadducci A; Facchini V; Ferdeghini M; Ceccarini T; Bartolini T; Fontana V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1988; 109(4):199-204. PubMed ID: 3232907
[No Abstract] [Full Text] [Related]
20. CA125 as a serum marker for poor prognosis in ovarian malignancies.
Alvarez RD; To A; Boots LR; Shingleton HM; Hatch KD; Hubbard J; Soong SJ; Potter ME
Gynecol Oncol; 1987 Mar; 26(3):284-9. PubMed ID: 2435619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
